Tenet Healthcare Corp. (NYSE:THC) – Analysts at Leerink Swann decreased their FY2016 earnings per share (EPS) estimates for Tenet Healthcare Corp. in a research note issued on Wednesday. Leerink Swann analyst A. Gupte now forecasts that the firm will earn $1.21 per share for the year, down from their prior estimate of $1.60. Leerink Swann currently has a “Market Perform” rating and a $28.00 target price on the stock. Leerink Swann also issued estimates for Tenet Healthcare Corp.’s Q4 2016 earnings at $0.21 EPS, FY2017 earnings at $2.03 EPS and FY2019 earnings at $2.57 EPS.

THC has been the topic of several other reports. Wolfe Research initiated coverage on Tenet Healthcare Corp. in a research note on Tuesday, October 25th. They set a “market perform” rating on the stock. Mizuho reduced their price objective on Tenet Healthcare Corp. from $28.00 to $22.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 5th. Barclays PLC reissued a “buy” rating and set a $39.00 price objective on shares of Tenet Healthcare Corp. in a research note on Friday, August 19th. TheStreet cut Tenet Healthcare Corp. from a “hold” rating to a “sell” rating in a research note on Friday, October 7th. Finally, Zacks Investment Research upgraded Tenet Healthcare Corp. from a “hold” rating to a “buy” rating and set a $24.00 target price for the company in a research report on Tuesday, October 4th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and seven have assigned a buy rating to the company. Tenet Healthcare Corp. presently has an average rating of “Hold” and a consensus price target of $30.69.

Earnings History and Estimates for Tenet Healthcare Corp. (NYSE:THC)

COPYRIGHT VIOLATION NOTICE: This piece was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The original version of this piece can be read at https://www.thecerbatgem.com/2016/11/28/fy2016-eps-estimates-for-tenet-healthcare-corp-decreased-by-analyst-thc.html.

Tenet Healthcare Corp. (NYSE:THC) opened at 16.22 on Monday. The stock has a 50 day moving average price of $19.53 and a 200 day moving average price of $24.94. Tenet Healthcare Corp. has a 12 month low of $14.06 and a 12 month high of $35.35. The company’s market cap is $1.62 billion.

Tenet Healthcare Corp. (NYSE:THC) last announced its earnings results on Monday, October 31st. The company reported $0.16 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by $0.01. Tenet Healthcare Corp. had a positive return on equity of 12.75% and a negative net margin of 1.04%. The firm earned $4.85 billion during the quarter, compared to the consensus estimate of $2.28 billion. During the same period in the prior year, the company posted $0.29 EPS. The firm’s revenue was up 3.3% on a year-over-year basis.

In other news, Director Ronald A. Rittenmeyer purchased 15,000 shares of the stock in a transaction that occurred on Friday, November 11th. The stock was purchased at an average price of $14.35 per share, for a total transaction of $215,250.00. Following the completion of the acquisition, the director now owns 23,783 shares of the company’s stock, valued at $341,286.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Peter M. Wilver bought 5,000 shares of the stock in a transaction on Wednesday, November 9th. The shares were bought at an average price of $15.19 per share, with a total value of $75,950.00. Following the acquisition, the director now owns 5,000 shares of the company’s stock, valued at $75,950. The disclosure for this purchase can be found here. 2.90% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: This piece was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The original version of this piece can be read at https://www.thecerbatgem.com/2016/11/28/fy2016-eps-estimates-for-tenet-healthcare-corp-decreased-by-analyst-thc.html.

A number of hedge funds have recently bought and sold shares of THC. Tower Research Capital LLC TRC raised its stake in Tenet Healthcare Corp. by 222.2% in the second quarter. Tower Research Capital LLC TRC now owns 3,647 shares of the company’s stock worth $101,000 after buying an additional 2,515 shares in the last quarter. US Bancorp DE raised its stake in Tenet Healthcare Corp. by 0.9% in the second quarter. US Bancorp DE now owns 3,879 shares of the company’s stock worth $107,000 after buying an additional 33 shares in the last quarter. Emerald Acquisition Ltd. bought a new stake in Tenet Healthcare Corp. during the second quarter worth $142,000. Creative Planning raised its stake in Tenet Healthcare Corp. by 618.0% in the third quarter. Creative Planning now owns 6,354 shares of the company’s stock worth $144,000 after buying an additional 5,469 shares in the last quarter. Finally, Acadian Asset Management LLC raised its stake in Tenet Healthcare Corp. by 1,534.5% in the second quarter. Acadian Asset Management LLC now owns 6,211 shares of the company’s stock worth $171,000 after buying an additional 5,831 shares in the last quarter.

Tenet Healthcare Corp. Company Profile

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company operates through three segments: Hospital Operations and other, Ambulatory Care and Conifer.

5 Day Chart for NYSE:THC

Receive News & Stock Ratings for Tenet Healthcare Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corp. and related stocks with our FREE daily email newsletter.